Evidence map›Paper›PMID 41761238›Full record

SynthesisBMC medicine2026

Detection of hearing loss by formal audiological testing after acute infectious meningitis: a global systematic review and meta-analysis.

Luisa F Alviz, Carla Y Kim, Ana Claudia Benevides-Tadinac, Jackson A Roberts, Lauren E Monette, Caroline E Harrer, Francisco J Varela, Soonmyung A Hwang, Blen M Gebresilassie, Pilar Balcarce and 10 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Luisa F AlvizProgram in Neuroinfectious Diseases, Department of Neurology, Columbia University Irving Medical Center, Milstein Hospital, 177 Fort Washington Avenue, New York, NY, 8GS-39910032, USA.
Carla Y KimProgram in Neuroinfectious Diseases, Department of Neurology, Columbia University Irving Medical Center, Milstein Hospital, 177 Fort Washington Avenue, New York, NY, 8GS-39910032, USA.
Ana Claudia Benevides-TadinacDepartment of Neurology, University of South Carolina School of Medicine Columbia, 8 Medical Park Drive, Suite 420, Columbia, SC, 29203, USA.
Jackson A RobertsProgram in Neuroinfectious Diseases, Department of Neurology, Columbia University Irving Medical Center, Milstein Hospital, 177 Fort Washington Avenue, New York, NY, 8GS-39910032, USA.
Lauren E MonetteProgram in Neuroinfectious Diseases, Department of Neurology, Columbia University Irving Medical Center, Milstein Hospital, 177 Fort Washington Avenue, New York, NY, 8GS-39910032, USA.
Caroline E HarrerLaboratory of Molecular Immunology, The Rockefeller University, 1230 York Avenue, New York, NY, 10065, USA.
Francisco J VarelaDepartment of Neurology, Fleni Institute, Montañeses 2325, Belgrano, Buenos Aires, 1428, Argentina.
Soonmyung A HwangIcahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, 10029, USA.
Blen M GebresilassieProgram in Neuroinfectious Diseases, Department of Neurology, Columbia University Irving Medical Center, Milstein Hospital, 177 Fort Washington Avenue, New York, NY, 8GS-39910032, USA.
Pilar BalcarceDepartment of Neurology, Fleni Institute, Montañeses 2325, Belgrano, Buenos Aires, 1428, Argentina.
Manya PrasadCentre for Community Medicine, All India Institute of Medical Sciences, Old OT Block, Room 30, Ansari Nagar, New Delhi, 110029, India.
John UsseglioAugustus C. Long Health Sciences Library, Columbia University Irving Medical Center, Hammer Health Sciences Center, Lobby Level, 701 West 168th Street, New York, NY, 10032, USA.
Kavita U KothariLibrary & Digital Information Networks, World Health Organization, Avenue Appia 20, Geneva 27, 1211, Switzerland.
Francesco VenutiDepartment of Mental Health, Brain Health Unit, Brain Health and Substance Use, World Health Organization, Avenue Appia 20, Geneva 27, 1211, Switzerland.
Nicoline SchiessDepartment of Mental Health, Brain Health Unit, Brain Health and Substance Use, World Health Organization, Avenue Appia 20, Geneva 27, 1211, Switzerland.
Yohane GadamaMedicine Department, School of Medicine and Oral Health, Kamuzu University of Health Sciences, Blantyre, Malawi.
Nicolò BinelloEmerging Zoonoses and High Impact Epidemics Unit, Epidemic and Pandemic Threat Management Department, Health Emergencies Programme, World Health Organization, Avenue Appia 20, Geneva 27, 1211, Switzerland.
Shelly ChadhaDepartment of Mental Health, Brain Health Unit, Brain Health and Substance Use, World Health Organization, Avenue Appia 20, Geneva 27, 1211, Switzerland.
Tarun DuaDepartment of Mental Health, Brain Health Unit, Brain Health and Substance Use, World Health Organization, Avenue Appia 20, Geneva 27, 1211, Switzerland.
Kiran T ThakurProgram in Neuroinfectious Diseases, Department of Neurology, Columbia University Irving Medical Center, Milstein Hospital, 177 Fort Washington Avenue, New York, NY, 8GS-39910032, USA. ktt2115@cumc.columbia.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute community-acquired bacterial meningitis remains a significant global health concern with significant mortality and morbidity, including neurological sequelae such as sensorineural hearing loss (SNHL). Early detection of meningitis-associated SNHL mitigates permanent deafness and poor outcomes, including cognitive decline, social isolation, and mental health disorders. This systematic review evaluates the optimal time point(s) to perform formal audiological diagnostic testing and follow-up in adult and pediatric meningitis patients to effectively detect hearing loss (HL) outcomes.

methodsA literature search was conducted across Medline, Embase, and Cochrane databases. Studies reporting the time frames for HL detection secondary to acute meningitis using formal audiological tests were included. Data were analyzed descriptively for continuous and categorical variables. A meta-analysis calculated the pooled prevalence of outcomes, with subgroup analyses stratified by the time frame of audiological diagnostic assessment.

resultsA total of 41 studies were included, with n = 8105 meningitis patients comprising n = 1397 (17.2%) adults and 6708 (82.8%) children. In adults, most audiological testing occurred post-discharge (n = 530 vs. n = 145), yet the proportion of hearing loss diagnoses was higher before discharge than after (45.5% vs. 42.5%). Similarly, more audiological assessments were administered post-discharge compared to pre-discharge (n = 3340 vs. n = 1975) in children, but HL diagnoses were more frequent before discharge (33.9% vs. 25.3%). The pooled prevalence of HL diagnoses during hospitalization or at discharge was 30.4% (95% CI 22.9-38%), compared to 22.9% (95% CI 12.6-33.1%) within 1 month post-discharge, 20.3% (95% CI 8.8-31.9%) between 30 and 60 days post-discharge, 22.7% (95% CI 12.1-33.4%) between 60 and 180 days post-discharge, and 10.8% (95% CI 5.9-15.7%) more than 180 days after discharge.

conclusionsThe considerable variability in the time frame of audiological test administration following an acute meningitis episode highlights the need for standardized auditory evaluations after meningitis diagnosis. Our findings emphasize that as hearing loss may occur and recover at different stages after an infectious meningitis episode, coordinated hearing assessments at discharge and during follow-up are important to ensure adequate detection and care.

Indexed as

Hearing LossHearing Loss, SensorineuralHearing TestsMeningitis, BacterialAdultAuditory AcuityChildHumansAcute meningitisAudiological testHearing impairmentSensorineural hearing loss

Identifiers

PMID41761238
PMCPMC12955278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.